Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kathleen M Giacomini

Showing results (1-10 of 222) with videos related to

Pageof 23
Sort By:
Clinical Pharmacology and Therapeutics|April 18, 2023
Biomarkers Come of Age in Clinical PharmacologyKathleen M Giacomini
Clinical Pharmacology and Therapeutics|May 19, 2025
Leading the Way: Multi-Drug Resistance Protein (MDR1) and Clinical Pharmacology-Commentary on Kim et alKathleen M Giacomini
Clinical Pharmacology and Therapeutics|April 12, 2025
MRI Provides New Insights Into the Pharmacologic Mechanism of Bisacodyl: A Blueprint for Understanding Intestinal Drug MechanismsKathleen M Giacomini
Clinical Pharmacology and Therapeutics|April 19, 2020
Novel Technologies Enable Mechanistic Understanding and Modeling of Drug Exposure and ResponseKathleen M Giacomini
Clinical Advances in Hematology & Oncology : H&O|December 9, 2016
The use of drug transporters as therapeutic targetsKathleen M Giacomini
Journal of Pharmaceutical Sciences|May 13, 2017
Transporters Involved in Metformin Pharmacokinetics and Treatment ResponseXiaomin Liang, Kathleen M Giacomini
Molecular Cancer Therapeutics|January 22, 2011
Interactions of tyrosine kinase inhibitors with organic cation transporters and multidrug and toxic compound extrusion proteinsTsuyoshi Minematsu, Kathleen M Giacomini
Pharmacogenetics|September 16, 2003
Estimating the contribution of genes and environment to variation in renal drug clearanceMaya K Leabman, Kathleen M Giacomini
Clinical Pharmacology and Therapeutics|August 22, 2022
More Than Pharmacokinetics: Transporters in Clinical PharmacologyKathleen M Giacomini, Shiew Mei Huang
Clinical Pharmacology and Therapeutics|October 13, 2017
Reverse Translational Research of ABCG2 (BCRP) in Human Disease and Drug ResponseDeanna J Brackman, Kathleen M Giacomini
Pageof 23

Showing results (1-10 of 222) with videos related to

Sort By:
Pageof 23
Clinical Pharmacology and Therapeutics|April 18, 2023
Biomarkers Come of Age in Clinical PharmacologyKathleen M Giacomini
Clinical Pharmacology and Therapeutics|May 19, 2025
Leading the Way: Multi-Drug Resistance Protein (MDR1) and Clinical Pharmacology-Commentary on Kim et alKathleen M Giacomini
Clinical Pharmacology and Therapeutics|April 12, 2025
MRI Provides New Insights Into the Pharmacologic Mechanism of Bisacodyl: A Blueprint for Understanding Intestinal Drug MechanismsKathleen M Giacomini
Clinical Pharmacology and Therapeutics|April 19, 2020
Novel Technologies Enable Mechanistic Understanding and Modeling of Drug Exposure and ResponseKathleen M Giacomini
Clinical Advances in Hematology & Oncology : H&O|December 9, 2016
The use of drug transporters as therapeutic targetsKathleen M Giacomini
Journal of Pharmaceutical Sciences|May 13, 2017
Transporters Involved in Metformin Pharmacokinetics and Treatment ResponseXiaomin Liang, Kathleen M Giacomini
Molecular Cancer Therapeutics|January 22, 2011
Interactions of tyrosine kinase inhibitors with organic cation transporters and multidrug and toxic compound extrusion proteinsTsuyoshi Minematsu, Kathleen M Giacomini
Pharmacogenetics|September 16, 2003
Estimating the contribution of genes and environment to variation in renal drug clearanceMaya K Leabman, Kathleen M Giacomini
Clinical Pharmacology and Therapeutics|August 22, 2022
More Than Pharmacokinetics: Transporters in Clinical PharmacologyKathleen M Giacomini, Shiew Mei Huang
Clinical Pharmacology and Therapeutics|October 13, 2017
Reverse Translational Research of ABCG2 (BCRP) in Human Disease and Drug ResponseDeanna J Brackman, Kathleen M Giacomini
Pageof 23